The changing character of diabetes complications
- PMID: 34861152
- DOI: 10.1016/S2213-8587(21)00313-2
The changing character of diabetes complications
Conflict of interest statement
SB received speaker fees and honoraria from Boehringer Ingelheim, Eli Lilly, MSD, and AstraZeneca, and received support to attend educational meetings from Napp, AstraZeneca, Eli Lilly, and Sanofi-aventis.
Comment in
-
Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records.Lancet Diabetes Endocrinol. 2022 Jan;10(1):46-57. doi: 10.1016/S2213-8587(21)00288-6. Epub 2021 Nov 30. Lancet Diabetes Endocrinol. 2022. PMID: 34861153 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical